Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Pandoraon May 13, 2022 11:21am
259 Views
Post# 34681620

RE:RE:Confusion on warrant expiry date

RE:RE:Confusion on warrant expiry date

1) Warrants issued with completed financing of January 2019:

Each Warrant entitles the holder to acquire an additional Common Share at an exercise price of $0.50 per share for a period of 24 months following the date of issuance. (i.e. January 9, 2019)

Please note news issued on January 8, 2021:

The Warrants were issued on January 9, 2019 pursuant to a private placement involving the issuance of 4,095,157 units of the Company. The Company proposes to extend the expiry date of the Warrants that remain outstanding from the original expiry date of January 9, 2021 to January 9, 2023.

2) Warrants issued with completed financing of August 2019:

Each Warrant shall be exercisable to acquire one Common Share at a price of $0.35 until August 22, 2024.

3) Warrants issued with completed financing of Oct.3, 2018:

Each Warrant entitles the holder to acquire an additional Common Share at an exercise price of $0.50 per share for a period of 24 months following the date of issuance. (i.e. Oct. 3, 2020)

Please note news issued September 30, 2020:

The Company proposes to extend the expiry date of the Warrants that remain outstanding from the original expiry date of October 3, 2020 to October 3, 2022.

4) Warrants issued with completed financing of May 14, 2018:

Each Warrant entitles the holder to acquire an additional Common Share at an exercise price of $0.30 per share for a period of 24 months following the date of issuance. (i.e. May 14, 2020)

Please note news issued May 11, 2014:

The Warrants were issued on May 14, 2018 pursuant to a private placement involving the issuance of 5,104,000 units of the Company. The Company proposes to extend the expiry date of the Warrants that remain outstanding from the original expiry date of May 14, 2020 to May 14, 2022.

** With this being May 13, and no news out thus far, it appears these warrants will be left to expire tomorrow.
<< Previous
Bullboard Posts
Next >>